Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors. Its dose–response relationships with respect to side effects ...
Findings from observational studies suggest that dietary patterns may offer protective benefits against cognitive decline, but data from clinical trials are limited. The Mediterranean–DASH ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback